- Home
- EM vs NLSP Comparison
EM vs NLSP Comparison
Compare EM & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EM
- NLSP
- Stock Information
- Founded
- EM 2017
- NLSP 2015
- Country
- EM China
- NLSP Switzerland
- Employees
- EM N/A
- NLSP N/A
- Industry
- EM Other Consumer Services
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- EM Consumer Discretionary
- NLSP Health Care
- Exchange
- EM Nasdaq
- NLSP Nasdaq
- Market Cap
- EM 215.7M
- NLSP 243.8M
- IPO Year
- EM 2021
- NLSP 2021
- Fundamental
- Price
- EM $0.72
- NLSP $3.37
- Analyst Decision
- EM Strong Buy
- NLSP
- Analyst Count
- EM 1
- NLSP 0
- Target Price
- EM $1.00
- NLSP N/A
- AVG Volume (30 Days)
- EM 52.4K
- NLSP 626.4K
- Earning Date
- EM 11-29-2024
- NLSP 11-29-2024
- Dividend Yield
- EM N/A
- NLSP N/A
- EPS Growth
- EM N/A
- NLSP N/A
- EPS
- EM 0.03
- NLSP N/A
- Revenue
- EM $269,745,696.00
- NLSP N/A
- Revenue This Year
- EM N/A
- NLSP N/A
- Revenue Next Year
- EM $6.16
- NLSP N/A
- P/E Ratio
- EM $22.05
- NLSP N/A
- Revenue Growth
- EM N/A
- NLSP N/A
- 52 Week Low
- EM $0.43
- NLSP $3.00
- 52 Week High
- EM $1.18
- NLSP $29.08
- Technical
- Relative Strength Index (RSI)
- EM 53.78
- NLSP 37.40
- Support Level
- EM $0.69
- NLSP $3.01
- Resistance Level
- EM $0.75
- NLSP $3.55
- Average True Range (ATR)
- EM 0.04
- NLSP 0.43
- MACD
- EM 0.00
- NLSP -0.01
- Stochastic Oscillator
- EM 78.57
- NLSP 20.98
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.